Table 4.

Heterozygosity for ena dominantly suppresses commissure defects in fra, Netrin and trio,Abl mutant embryos

Genotype% Defective segments, overall (n)% Segments with thin/missing commissures% Segments with path-finding errors
trioM89,Abl1/Df(3L)FpaI,Abl4 100 (160) 86 14 
enaGC10/+;trioM89,Abl1/Df(3L)FpaI,Abl4 78 (206) 65 13 
Df(3L)FpaI,Abl4/trioIMP159.4,Abl1 85 (196) 65 20 
enaGC5/+;Df(3L)FpaI,Abl4/trioIMP159.4,Abl1 29 (208) 20 
fra4/Df(2R)vg135 21 (1279) 13 
fra4,enaGC10/Df(2R)vg135 17 (799) 10 
Df(1)NP5/Y 34 (277) 24 10 
Df(1)NP5/Y;enaGC10/+ 17 (308) 10 
Df(1)NP5/Y;ena210/+ 26 (222) 11 15 
Df(1)NP5/Y;ena23/+ 20 (212) 13 
fra4/fra4 36 (212) 23 13 
fra4/fra4;Abl4/+ 45 (458) 33 12 
fra4,enaGC10/fra4;Abl4/+ 26 (221) 14 12 
fra4/fra4;trioIMP159.4/+ 90 (213) 80 10 
fra4,enaGC10/fra4;trioIMP159.4/+ 25 (197) 15 10 
Genotype% Defective segments, overall (n)% Segments with thin/missing commissures% Segments with path-finding errors
trioM89,Abl1/Df(3L)FpaI,Abl4 100 (160) 86 14 
enaGC10/+;trioM89,Abl1/Df(3L)FpaI,Abl4 78 (206) 65 13 
Df(3L)FpaI,Abl4/trioIMP159.4,Abl1 85 (196) 65 20 
enaGC5/+;Df(3L)FpaI,Abl4/trioIMP159.4,Abl1 29 (208) 20 
fra4/Df(2R)vg135 21 (1279) 13 
fra4,enaGC10/Df(2R)vg135 17 (799) 10 
Df(1)NP5/Y 34 (277) 24 10 
Df(1)NP5/Y;enaGC10/+ 17 (308) 10 
Df(1)NP5/Y;ena210/+ 26 (222) 11 15 
Df(1)NP5/Y;ena23/+ 20 (212) 13 
fra4/fra4 36 (212) 23 13 
fra4/fra4;Abl4/+ 45 (458) 33 12 
fra4,enaGC10/fra4;Abl4/+ 26 (221) 14 12 
fra4/fra4;trioIMP159.4/+ 90 (213) 80 10 
fra4,enaGC10/fra4;trioIMP159.4/+ 25 (197) 15 10 

Percentages were not rounded when overall defects were less than 15%.

Close Modal

or Create an Account

Close Modal
Close Modal